Bradycardia Flashcards
7 cards from real ACLS practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 Bradycardia flashcards as text
A patient presents with a heart rate of 38 bpm, hypotension, and altered mental status. Which drug is the FIRST-LINE treatment for symptomatic bradycardia?
Answer: Atropine
Atropine 1 mg IV is the first-line drug for symptomatic bradycardia in ACLS guidelines.
What is the maximum cumulative dose of atropine recommended in ACLS for bradycardia?
Answer: 3 mg
The maximum cumulative dose of atropine is 3 mg (given as repeated 1 mg doses every 3–5 minutes).
A patient with symptomatic bradycardia fails to respond to atropine. Which of the following is the NEXT best step?
Answer: Begin transcutaneous pacing
Transcutaneous pacing is the recommended intervention when atropine fails to improve symptomatic bradycardia.
Which rhythm is most likely to be UNRESPONSIVE to atropine therapy?
Answer: Third-degree AV block with wide QRS escape
Complete heart block with a wide-complex (ventricular) escape rhythm is below the AV node and does not respond to atropine.
During transcutaneous pacing for bradycardia, what confirms electrical capture?
Answer: Widened QRS complexes after each pacing spike with a pulse
Electrical capture is confirmed by a pacing spike followed by a wide QRS, and mechanical capture is confirmed by a palpable pulse.
An ACLS provider considers dopamine infusion for a bradycardic patient. What is the correct dose range for dopamine when used for rate support?
Answer: 2–10 mcg/kg/min
Dopamine at 2–10 mcg/kg/min provides chronotropic and inotropic effects useful in symptomatic bradycardia.
A patient with bradycardia has no symptoms — normal blood pressure, no chest pain, no altered mentation. What is the appropriate ACLS action?
Answer: Observe and monitor; no immediate intervention required
Asymptomatic bradycardia does not require treatment; ACLS intervention is indicated only when signs or symptoms are present.